Articles related to CLINICAL TRIALS

The study suggests that approximately one heated yoga session per week was associated with significantly greater reduction in depression symptoms than a waitlist control. This finding indicates that heated yoga could be a viable non-medication-based treatment option for patients with moderate-to-severe depression.

The recent findings on valbenazine’s fast onset of action in treating chorea associated with HD could be a game-changer for the 30,000 Americans living with this disease.

This study provides valuable insights into the comparative benefits and risks of rosuvastatin and atorvastatin in adults with coronary artery disease. Notably, while both drugs showed comparable efficacy, rosuvastatin was associated with a higher risk of new onset diabetes mellitus and cataract surgery.

With a complete metabolic response rate of 82.1% after just four cycles of induction, this new regimen could change how we approach treatment for young patients with low risk, relapsed classical Hodgkin lymphoma.

This phase 2 trial demonstrated that tarlatamab showed antitumor activity with durable objective responses and promising survival outcomes in patients with previously treated small-cell lung cancer. With a manageable safety profile and no new safety signals identified, tarlatamab could represent a significant advancement in the treatment landscape for these patients.

The phase 3 trial showed that enzalutamide, when used as a monotherapy or in combination with leuprolide, resulted in superior metastasis-free survival rates for patients with high-risk biochemical recurrence of prostate cancer.